AllResearch & Discoveries184Diagnosis & Detection61Genetics & Risk Factors38Treatment & Clinical Trials43Prevention & Lifestyle59Caregiving & Living With9
Category
Clinical Trials & Research Updates
Latest news on Alzheimer's clinical trials, drug testing, and new therapies.
43 summariesUpdated today5 sources
43 articles found
Oct 5, 2026Treatment & Clinical TrialsTrial testing cholesterol-lowering med as potential Alzheimer’s interventionNewAmsterdam Pharma has dosed the first participant in a mid-stage US trial testing whether its LDL-lowering pill obicetrapib affects preclinical Alzheimer'sAlzheimer's News Today – The Web's Daily Resource for Alzheimer's NewsSep 25, 2026Treatment & Clinical TrialsBlood proteins may help monitor Alzheimer’s treatment responseA Washington University study of 197 lecanemab patients found dozens of blood proteins that shift during treatment, hinting at a cheaper way to track responseNews Medical Alzheimers Disease News FeedSep 22, 2026Treatment & Clinical TrialsGalimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101Galimedix has formed an Alzheimer's scientific advisory board to guide clinical development of GAL-101, its oral drug candidateNews Medical Alzheimers Disease News FeedSep 15, 2026Treatment & Clinical TrialsStudy explains why Amazonian Indigenous populations show low dementia prevalenceNew longitudinal data suggest low dementia prevalence among Bolivia's Tsimane and Moseten reflects shorter survival after diagnosis, not fewer new casesNews Medical Alzheimers Disease News FeedSep 8, 2026Treatment & Clinical TrialsAt-home injection version of Alzheimer’s drug now available in USThe FDA has cleared Leqembi Iqlik, an at-home autoinjector version of lecanemab, for the full course of early Alzheimer's treatment, not just maintenanceAlzheimer's News Today – The Web's Daily Resource for Alzheimer's NewsAug 14, 2026Treatment & Clinical TrialsWomen taking estrogen had fewer signs of Alzheimer’s in their brainsA Neurology study of more than 21,000 women links later-life hormone therapy to lower dementia risk, though researchers stress it proves no cause and effectDementia News -- ScienceDailyAug 13, 2026Treatment & Clinical TrialsLater-life estrogen therapy associated with lower risk of developing dementiaWomen who began estrogen-only hormone therapy after age 70 had a lower risk of dementia, according to a study of more than 21,000 women in NeurologyNews Medical Alzheimers Disease News FeedAug 12, 2026Treatment & Clinical TrialsModern blood thinners slow cognitive decline in Alzheimer's patientsA Karolinska Institutet study of 7,308 patients found slower cognitive decline in people with Alzheimer's and atrial fibrillation treated with NOAC blood thinners.News Medical Alzheimers Disease News FeedAug 6, 2026Treatment & Clinical TrialsStudy reveals treatment gaps for atypical Alzheimer's disease patientsMost patients with atypical Alzheimer's, which strikes language or vision before memory, may not qualify for new anti-amyloid drugs, a Neurology study finds.News Medical Alzheimers Disease News FeedAug 3, 2026Treatment & Clinical TrialsFDA designation may speed new treatment for Alzheimer’s psychosisThe FDA has granted fast track status to remlifanserin, Acadia's experimental therapy for the hallucinations and delusions of Alzheimer's psychosisAlzheimer's News Today – The Web's Daily Resource for Alzheimer's NewsJul 28, 2026Treatment & Clinical TrialsTHC and CBD combination rapidly reduces advanced dementia agitationTopline Phase 2 results show a low-dose THC/CBD oil rapidly eased agitation in hospice-eligible dementia patients, meeting the trial's main goalsNews Medical Alzheimers Disease News FeedJul 14, 2026Treatment & Clinical TrialsMedical THC and CBD formulation significantly reduces late-life dementia agitationA medical THC-CBD formulation cut agitation in hospice-eligible dementia patients, with nearly 90% improving over 12 weeks in the LiBBY trialNews Medical Alzheimers Disease News FeedJul 13, 2026Treatment & Clinical TrialsGlobal consortium releases AI toolbox to unlock new Alzheimer's treatmentsA 17-member global consortium led by WashU Medicine has released three free AI tools aimed at speeding up Alzheimer's drug discoveryNews Medical Alzheimers Disease News FeedJul 8, 2026Treatment & Clinical TrialsInvestigational drug ameliorates neuronal DNA damage and inflammation in Alzheimer's modelAn experimental drug, KCL-286, boosted DNA repair in neurons and cut brain inflammation in a mouse model of Alzheimer's, researchers report in FEBS Open Bio.News Medical Alzheimers Disease News FeedJul 8, 2026Treatment & Clinical TrialsNew review shows why antidepressants often fail in Alzheimer’s and Parkinson’s depressionA Molecular Psychiatry review argues standard antidepressants often fall short in Alzheimer's and Parkinson's because they miss the damaged brain circuits driving the depression.News Medical Alzheimers Disease News FeedJul 6, 2026Treatment & Clinical TrialsStudy reports Alzheimer’s treatment gains in long-term careTop-line results from the BEACON real-world study link Zunveyl to provider-reported gains in cognition, behavior and daily function in long-term care residents.Alzheimer's News Today – The Web's Daily Resource for Alzheimer's NewsJul 2, 2026Treatment & Clinical TrialsSmart prodrug targets Alzheimer's disease using hydrogen peroxide signalsKAIST researchers turned hydrogen peroxide, a damaging molecule elevated in Alzheimer's brains, into the trigger that switches on a drug only where disease is present.News Medical Alzheimers Disease News FeedJun 15, 2026Treatment & Clinical TrialsLab trials prove copper therapy enhances cognitive function and spatial learningMonash University researchers report that Cu(ATSM), a copper-delivering drug, restored a clogged waste-clearing pump at the blood-brain barrier and improved spatial memory in lab tests.News Medical Alzheimers Disease News FeedJun 8, 2026Treatment & Clinical TrialsResearchers develop compound 10 to slow Alzheimer's disease progressionETH Zurich researchers report that an experimental compound targeting the enzyme GRK2 slowed nerve cell death and extended survival in mice with Alzheimer's-like disease.News Medical Alzheimers Disease News FeedJun 5, 2026Treatment & Clinical TrialsAntibody fragment offers safer alternative for Alzheimer disease treatmentSpanish researchers have engineered a stripped-down antibody fragment against amyloid that avoids the brain bleeding seen with lecanemab and donanemab, so far in mice.News Medical Alzheimers Disease News FeedJun 1, 2026Treatment & Clinical TrialsWhy new Alzheimer’s drugs are dividing regulators worldwideA Lancet World Report finds regulators split over whether new Alzheimer's drugs deliver benefits big enough to justify their risks and costs.News Medical Alzheimers Disease News FeedMay 19, 2026Treatment & Clinical TrialsPopular analysis technique hides patient variability in Alzheimer's drug trialsBrown University researchers warn in JAMA Neurology that a grouping-and-averaging statistic used in Alzheimer's drug analyses can overstate how the drugs workNews Medical Alzheimers Disease News FeedMay 6, 2026Treatment & Clinical TrialsOrganic lithium salts may affect many cellular level changes in Alzheimer's diseaseA University of Eastern Finland study finds lithium chloride affects a range of cellular changes in Alzheimer's, adding to the case for organic lithium saltsNews Medical Alzheimers Disease News FeedMay 4, 2026Treatment & Clinical TrialsFDA approves Auvelity to treat Alzheimer’s-related agitationThe FDA has approved Auvelity (dextromethorphan-bupropion) for agitation in Alzheimer's disease, the first such treatment that is not an antipsychotic.Alzheimer's News Today – The Web's Daily Resource for Alzheimer's News